Introduction
Myocarditis is the representative of myocardial infl ammation of diverse aetiologies where viruses are the most common aetiological factor, predominantly enteroviruses (EV) and adenoviruses (AdV). Viral myocarditis accounts for up to one-third of the cases of dilated cardiomyopathy (DCM) characterised by cardiac dilation, diminished contraction of the left or both the ventricles which may further progress to heart failure and sudden cardiac death. [1] Acute myocarditis occurs as the fi rst phase of disease pathogenesis followed by the phase of immune response or sub-acute myocarditis and fi nally to cardiac remodeling phase leading to chronic January -March 2015 some SNPs regulate the production of TNF-α. [11, 12] There are few studies from different geographical areas where the association between the idiopathic DCM and the SNPs in TNF promoter region have been studied. [7, 12, 13] The objective of the present study was to explore the role of TNF-α promoter gene polymorphism at various loci in DCM cases with viral aetiology.
Materials and Methods

Subjects
The endomyocardial biopsies from 21 of histopathologically proven DCM cases were tested for the presence of adenovirus (AdV) and enterovirus (EV) genome by polymerase chain reaction (PCR) as described below. Of these 18 cases that were positive for AdV/EV genome were fi nally included as study group as viral DCM cases. Seventeen healthy individuals were included as control groups.T hree millilitres of blood was collected aseptically in a vial containing anticoagulant from both cases (n = 18) and controls (n = 17). The endomyocardial biopsies (EMBs) were collected for histopathological examination and viral genome detection. The tissue collected for molecular study were stored in RNA later (Ambion, USA) at -80°C till further use. Informed consent was taken from all the patients before EMB. The study protocol was approved by Institute's Ethics Committee.
Viral genome detection
Custom Taqman assays containing the primers and an FAM-labeled probe targeting hexon gene of AdV and 5'NTR of EV genome were developed from ABI, Foster City, CA, USA. The EMB was subjected to nucleic acid extraction using RNAqueous Isolation kit (Ambion). One half of the nucleic acid was treated with RNase enzyme to obtain DNA while the other half was treated with DNase I enzyme to get RNA. RNA (1 μg) extracted from the myocardial tissues was reverse transcribed to cDNA using high-effi ciency cDNA synthesis kit (Ambion) followed by Taqman Real Time PCR. The reaction mixture (25 μl) contained 1X TaqMan PCR master mix, 1.25 μl AdV or EV-specifi c primer-probe assay (ABI) and 500 ng of extracted DNA or 2 μl of cDNA. Real-time PCR assays were performed in ABI 7500 following the universal thermal profi le. For each run no template control and positive controls were included.
Study of TNF-α promoter polymorphism by PCR-RFLP
Genomic DNA was extracted from the whole blood using the QIAGEN DNA extraction kit as per the manufacturer's protocol and stored at -20°C until further use. The SNPs of -238G/A, -308G/A, -857 C/T and -863C/ A at the TNF-α promoter region were determined by the gene-specifi c PCR followed by restriction fragment length polymorphism (PCR-RFLP). The PCR was carried out using the specifi c primers as described earlier. [14] The amplifi ed products were visualised in 2% agarose gel stained with ethidium bromide. These PCR products were further subjected to restriction digestion by allele-specifi c restriction enzymes (MBI Fermentas, USA) by overnight incubation at 4°C. Cleaved DNA fragments were separated by 12% polyacrylamide gel electrophoresis and visualised by ethidium bromide staining. The allelic type was determined according to the presence or absence of the digested product of the desired length [ Table 1 ].
Statistical analysis
The data was analyzed using SPSS software version 16.0. The allele and genotype frequencies were examined by Hardy Weinberg Equilibrium test. The TNF-α promoter gene polymorphism in cases and controls was evaluated using χ2. SPSS was used to calculate odds ratio (OR) and 95% confi dence intervals (CI) for assessing the risk associated with particular allele and genotype. The 'P value' of < 0.05 was taken as signifi cant.
Results
EMBs from the clinically and histopathologically confi rmed DCM cases were tested for viral genome detection. Viral genome was detected by Real-time PCR using EV and AdV specifi c Taqman assay. Of the 18 DCM cases positive for viral genome, 4 (4/18; 22.2%) were positive for AdV genome, 2 (2/18; 11.1%) had EV positivity and 12 (12/18; 66.7%) cases had co-infection of AdV and EV.
The DCM cases with viral positivity were analyzed for polymorphism at TNF-α promoter position. The genotypic and allele frequency distribution for the four polymorphisms of -238G/A, -308G/A, -857C/T and -863C/A between the two study groups is listed in Table 2 . The allelic and genotypic frequencies were observed to be in Hardy-Weinberg equilibrium. The frequency distribution of the heterozygous GA genotype at -238 (χ 2 = 8.264; P =0.008; OR = 2.545; 95% CI = 1.606-4.034) and the frequency distribution of homozygous AA genotype at -863 were found to be statistically significant (χ 2 = 5.381; P =0.035; OR = 5.833; 95% CI = 1.231-27.632) in comparison to controls. However, no statistical difference was observed in the genotypic and allelic frequency distribution of -308G/A and -857C/T between the cases and controls [ Table 3 ]. Table 4 shows the possible association of viral DCM with TNF-α polymorphism.
Discussion
Myocarditis is the infl ammation of myocardium which can progress to DCM and heart failure in upto 30% of the patients. [1] Viruses have been implicated predominantly in Indian Journal of Medical Microbiology vol. 33, No. 1 the genesis and evolution of viral myocarditis and DCM. [15] [16] [17] Although 90% of the people get infected with one of the cardiotropic viruses in their life but only few develop clinical symptoms of myocarditis and progress to DCM. [18] This may be attributed to host genetic make-up which induces immune response alterations or increased susceptibility to viral infections. [3] The study on family background has shown an inherited gene mutation to be the cause of approximately 25-30% of idiopathic DCM. [19] However, the knowledge pertaining to genetics risk factors for DCM is yet to be explored.
Pro-infl ammatory cytokines, such as TNF-α has been found to produce various biological effects which include immune activation, stimulation of gene expression involved in infl ammatory response and cellular alteration through nitric oxide production. [20] Several studies suggest that TNF play a crucial pathophysiological role in the development of viral myocarditis and its progression to DCM. The effect of TNF-α on cardiac function depends on the amount and duration of TNF-α expression. As demonstrated in in-vitro models, TNF-α can affect heart by cardiomyocyte loss, through necrosis or apoptosis. Both animal model and human studies have shown upregulation of TNF-α mRNA and protein levels in hearts of patients during myocarditis and DCM. During the chronic stage of viral myocarditis, the persistence of TNF-α expression in the cardiovascular system is responsible for the infi ltration of leucocytes which leads to the myocardial damage. It has been observed that myocarditis is aggravated by exogenous administration of TNF whereas its neutralisation can attenuate myocarditis. [7, [21] [22] [23] The human TNF-α gene lies within the class III region of the major histocompatibility complex (MHC) in between HLA-B and DR. TNF has potent physiological actions and the 5' fl anking region of TNF-α gene regulates TNF-α production at transcriptional level. [24] Therefore, it is speculated that polymorphism in this locus may attribute to infectious or autoimmune diseases. The polymorphism of cytokines in DCM have been studied previously which included particularly TNF-α, IL-10 and IL-17. The anti-infl ammatory cytokines may infl uence the function of pro-infl ammatory cytokines and raised levels of IL-10 have been found in serum of patients with congestive heart failure though Ito et al., reported no signifi cant difference of IL-10 allele frequency at -1082 position in DCM cases as compared to control group. [12] Similarly, study conducted by Peng et al., explored the associations of IL-17 gene polymorphisms in Chinese patients with DCM and stated that rs2275913 and rs763780 polymorphisms in IL-17 genes were not responsible for disease outcome of DCM. However, polymorphisms of TNF-α promoter region in idiopathic DCM have been studied in different populations across the globe. [25] TNF-α promoter polymorphism has been studied at -308, -238, -857, -863, -1031 positions in DCM but none of these previous studies have simultaneously studied polymorphism at four loci (-308, -238, -857, -863) of TNF-α promoter region. [6, 12, 13] Thus, in the present study a possible association of TNFα -308, -238, -857, -863 polymorphism with viral DCM was explored.
Among the various aetiological factors of DCM, cardiotropic viruses like enterovirus and adenovirus, have been implicated as the most common cause. However, it has been observed from previous studies the predominance of virus and rate of co-infection vary with the geographical origin. The rate of enterovirus positivity has been reported from 1.2% to 27.3%, where as adenovirus positivity ranges from 2% to 12% in various studies. [15, 16, 26] The high positivity of enterovirus and adenovirus in DCM patients in our study as compared to previous studies can be due to the use of more sensitive technique i.e. Real-time PCR for positivity of cardiotropic viruses, difference in the inclusion criteria of DCM patients and different geographic origin of DCM patients studied. In the present study, 18 DCM cases positive for AdV or EV genome were further subjected to analysis for the association with TNF-α -238G/A,-308G/A, -863C/A and -857C/T polymorphism. The A allele frequency was signifi cantly high in DCM cases as compared to the controls (P < 0.05) thus, suggesting association of A allele polymorphism with DCM of viral aetiology. Few studies have demonstrated the polymorphism of TNF gene at various loci in idiopathic DCM cases. [7, 12, 13] The present study for the fi rst time demonstrated the association of TNF-α -238G/A and -863C/A polymorphism with DCM of viral aetiology.
The point mutation of G to A at position -308 and -238 of TNF promoter has been reported previously to predispose to higher TNF production. [27] Polymorphism at -863C/A, has been found to inhibit the binding of the NFκB p50-p50 homodimer to its domain in TNF promoter, where NF-κB acts as the transcriptional repressor. This inhibits down-regulation of TNF-α expression and thereby leading to increased TNF production. [28] Thus, from the results of the present study, it may be hypothesised that polymorphism at -238 and -863 possibly increases the TNF-α expression and susceptibility to viral infection which together may have attributed to the disease progression to DCM [ Figure 1 ]. However, additional studies including large number of samples are required to explain the proposed hypothesis in pathogenesis of viral DCM. Figure 1A , regulated production of TNF-α occurs after viral infection which may lead to the viral clearance but in the case of hosts having mutant alleles of TNF-α promoter gene i.e., 238GA and 863AA as shown in Figure 1B , after viral infection TNF-α over-expression may lead to disease progression to dilated cardiomyopathy b a Indian Journal of Medical Microbiology vol. 33, No. 1
Conclusions
TNFα -238G/A and -863C/A polymorphism was signifi cantly associated with DCM cases of viral aetiology suggesting the possible association of TNF-α polymorphism with susceptibility to viral infection and risks of DCM.
